HNWAG
VIGL

High Net Worth Advisory Group’s Vigil Neuroscience VIGL Stock Holding History

High Net Worth Advisory Group’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500
Closed -$4K – 727
2022
Q1 		$4K Buy
+500
New +$6.6K ﹤0.01% 612

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

High Net Worth Advisory Group's VIGL Position: Q2 2022 in Review

High Net Worth Advisory Group sold out of Vigil Neuroscience (VIGL) in Q2 2022, closing a stake of 500 shares — an estimated $4K sold.

High Net Worth Advisory Group first reported a position in VIGL in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 35 funds tracked by Wall St. Rank hold VIGL as of Q2 2022.

  • High Net Worth Advisory Group reported no remaining Vigil Neuroscience position as of Q2 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 500 Vigil Neuroscience shares in Q2 2022, an estimated $4K.
  • High Net Worth Advisory Group first reported a position in Vigil Neuroscience in Q1 2022 and held it in 1 quarter.
  • High Net Worth Advisory Group's Vigil Neuroscience position peaked at $4K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2022.

Based on High Net Worth Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.